On September 23, 2022, Jonathan Jorgl has filed a preliminary proxy statement soliciting proxies and urged the shareholders of AIM ImmunoTech Inc; 1) to vote for Robert L. Chioini and Michael Rice to the Company board and withhold for each of the incumbent nominees, 2) to vote against the Company proposal to approve, by non-binding vote, executive compensation at the Company's annual general meeting of shareholders scheduled to be held on November 3, 2022.